ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,587.24
      0.60%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sage Therapeutics Inc (SAGE)

      7. Sage Therapeutics Inc (SAGE) Financials

      Sage Therapeutics Inc

      Sage Therapeutics Inc (SAGE)

      Sage Potash Corp
      11.76
      0.025
      (0.21%)
      Closed July 13 4:00PM
      Delayed by 15 minutes
      11.76
      0.00
      (0.00%)
      After Hours: 6:00PM
      Delayed by 15 minutes

      Sage Therapeutics Inc Financial Summary

      The current SAGE market cap is 707.74M. The company's latest EPS is USD -8.9975 and P/E is -1.31.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 3.29M2.47M2.72M77.97M7.9M
      Operating Income -155.47M-170.46M-211.85M-42.07M-117.68M
      Net Income -146.83M-160.33M-201.63M-32.71M-108.48M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.87M1.11B6.31M7.69M86.46M
      Operating Income -708.12M596.23M-460.91M-546.99M-579.85M
      Net Income -680.24M606.07M-457.89M-532.78M-541.49M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.22B1.08B949.66M882.28M767.6M
      Total Liabilities 87.56M97.91M133M82.75M61.8M
      Total Equity 1.13B984.38M816.66M799.53M705.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.08B2.16B1.83B1.36B882.28M
      Total Liabilities 139.5M86.91M96.26M103.85M82.75M
      Total Equity 944.66M2.07B1.73B1.25B799.53M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -153.68M-285.2M-421.07M-540.59M-37.83M
      Investing 194.87M240.46M400.85M442.91M139.44M
      Financing 2.67M3.52M6.29M6.03M1.56M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -528.71M664.28M-378.18M-460.04M-540.59M
      Investing -143.16M442.68M-1B325.43M442.91M
      Financing 607.62M426.76M13.33M3.07M6.03M

      Stats and Ratios

      Market Cap 707.74M
      Price to Earnings Ratio -1.31
      Price to Sales Ratio 8.19
      Price to Cash Ratio 9.97
      Price to Book Ratio 0.89
      Dividend Yield -

      Share Statistics

      Shares Outstanding 60.18M
      Average Volume (1 week) 769.46k
      Average Volume (1 Month) 1.14M
      52 Week Change -76.30%
      52 Week High 49.74
      52 Week Low 9.76
      Spread (Intraday) 2.63 (21.16%)

      Company Info

      Company Name Sage Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.sagerx.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      SAGE
      Sage Therapeutics
      Delayed Upgrade Clock